Differential Pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction

World Journal of Surgery

Volumn 34, Issue 12, 2010, Pages 2821-2829

  Reynolds, John V ^a   Ravi, Narayanasamy ^a   Muldoon, Cian ^a   Larkin, John O ^a   Rowley, Suzanne ^a   O'Byrne, Ken ^b   Hollywood, Donal ^b   O'Toole, Dermot ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; ESOPHAGUS TUMOR; FACTUAL DATABASE; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78651320413     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0783-y     Document Type: Article

References (25)

1. Forman D (2004) Oesophago-gastric adenocarcinoma-an epidemiological perspective. Aliment Pharmacol Ther 20(SUPPL. 5):55-60
2. Devesa SS, Blot WJ, Fraumeni JF Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053
3. Siewert JR, Feith M, Werner M et al (2000) Adenocarcinoma of the esophagastric junction: results of surgical therapy based on anatomical/topographical classification in 1002 consecutive patients. Ann Surg 232:353-361
4. Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophago-gastric junction. Br J Surg 85:1457-1459
5. Humagilli U (1996) Resective surgery for cancer of the thoracic esophagus. Results of a consensus conference of the International Society for Diseases of the Esophagus. Dis Esophagus 9(SUPPL. 1):30-38
6. American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, New York
7. American Joint Committee on Cancer (2009) AJCC cancer staging manual, 7th edn. Springer, New York
8. Sobin LH, Gospodarowicz M, Wittekind C (2009) TMN classification of malignant tumours, 7th edn. Wiley-Blackwell, London
9. Jorgensen JT (2010) Targeted HER2 treatment in advanced gastric cancer. Oncology 78:26-33
10. Maher SG, Gillham CM, Duggan SP et al (2009) Gene expression analysis of diagnostic biopsies predicted pathological response to neoadjuvant chemoradiotherapy of esophageal cancer. Ann Surg 250:729-737
11. Reynolds JV, Muldoon C, Hollywood D et al (2007) Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 245:707-716
12. Cunningham D, Allum WH, Stenning SP, MAGIC Trial Participants et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20
13. Griffiths EA, Pritchard SA, Mapstone NP et al (2006) Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist. World J Surg Oncol 4:82-89
14. Mandard AM, Dalibard F, Mandard JC et al (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73:2680-2686
15. Leers JM, De Meester SR, Chan N et al (2009) Clinical characteristics, biologic behaviour, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J Thorac Cardiovasc Surg 138: 594-602
16. Siewert JR, Feith M (2007) Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer. J Am Coll Surg 205:S48-S53
17. Mattioli S, Ruffato A, Di Simone MP et al (2007) Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors. Ann Thorac Surg 83:1814-1819
18. Cahu I, Norman AR, Cunningham D et al (2009) The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma-individual patient data from 1775 patients in four randomised controlled trials. Ann Oncol 20:885-891
19. Chandrasoma P, Wickramasinge K, Ma Y et al (2007) Adenocarcinoma of the distal esophagus and "gastric cardia" are predominantly esophageal adenocarcinomas. Am J Surg Pathol 31:569-575
20. Chandrasoma P, Makareticz K, Wickramasinge K et al (2006) A proposal for a new validated histologic definition of the gastroesophageal junction. Hum Pathol 37:40-47
21. Lagergren J, Bergstrom R, Lindgren A et al (1999) Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831
22. Mariette C, Piessen G, Briez N et al (2008) The number of metastatic nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365-371
23. Peyre CG, Hagen JA, De Meester SR et al (2008) The number of lymph nodes predicts survival in esophageal cancer: an international study on the extent of surgical resection. Ann Surg 248:549-556
24. Lamb PJ, Griffin SM, Burt AD et al (2005) Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 92:60-67
25. Barbour AP, Rizk NP, Gonnen N et al (2007) Adenocarcinoma of the gastroesophageal junction: influence of surgical resection margin and operative approach on outcome. Ann Surg 246:1-8